The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid
Open accessAbstract
A common feature in the Alzheimer's disease (AD) brain is the presence of acetylcholinesterase (AChE) which is commonly associated with β-amyloid plaques and neurofibrillary tangles (NFT). Although our understanding of the relationship between AChE and the pathological features of AD is incomplete, increasing evidence suggests that both β-amyloid protein (Aβ) and abnormally hyperphosphorylated tau (P-tau) can influence AChE expression. We also review recent findings which suggest the possible role of AChE in the development of a vicious cycle of Aβ and P-tau dysregulation and discuss the limited and temporary effect of therapeutic intervention with AChE inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Molecular and cellular biology of cholinesterases
Massoulié, J., Pezzementi, L., Bon, S., Krejci, E., & Vallette, F.-M. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90040-y · Cited by 1,214
History of lectins: from hemagglutinins to biological recognition molecules
Sharon, N. (2004) · Glycobiology · doi:10.1093/glycob/cwh122 · Cited by 1,128
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
The Cholinesterases: From Genes to Proteins
Taylor, P., & Radic, Z. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001433 · Cited by 669
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Acetylcholinesterase: ‘classical’ and ‘non-classical’ functions and pharmacology
Silman, I., & Sussman, J. L. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.014 · Cited by 524
Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.-P., & van den Bussche, H. (2005) · BMJ · doi:10.1136/bmj.331.7512.321 · Cited by 522
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Acetylcholinesterase in Alzheimer's disease
Talesa, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00309-8 · Cited by 450
The cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 409
Structural roles of acetylcholinesterase variants in biology and pathology
Grisaru, D., Sternfeld, M., Eldor, A., Glick, D., & Soreq, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00693.x · Cited by 355
Cholinesterases: Roles in the Brain During Health and Disease
Ballard, C., Greig, N., Guillozet-Bongaarts, A., Enz, A., & Darvesh, S. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367838 · Cited by 350
Arendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314
The Origin of the Molecular Diversity and Functional Anchoring of Cholinesterases
Massoulié, J. (2002) · Neurosignals · doi:10.1159/000065054 · Cited by 281
Glycosylation differences between the normal and pathogenic prion protein isoforms
Rudd, P. M., Endo, T., Colominas, C., Groth, D., Wheeler, S. F., Harvey, D. J., Wormald, M. R., Serban, H., Prusiner, S. B., Kobata, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13044 · Cited by 273
Melo, J. B., Agostinho, P., & Oliveira, C. R. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(02)00201-8 · Cited by 271
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimers Disease
Munoz-Torrero, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909067 · Cited by 253
Perrier, A. L., Massoulié, J., & Krejci, E. (2002) · Neuron · doi:10.1016/s0896-6273(01)00584-0 · Cited by 248
Wright, C. I., Geula, C., & Mesulam, M. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410340312 · Cited by 219
The cholinergic innervation of the human cerebral cortex.
Mesulam, M.-M. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45004-8 · Cited by 211 · cited 1×
“We particularly refer to the work of Mesulam (2004) for a detailed view of the distribution of AChE in the non-pathological and AD brain.”
BackgroundAtack, J. R., Perry, E. K., Bonham, J. R., Perry, R. H., Tomlinson, B. E., Blessed, G., & Fairbairn, A. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90302-6 · Cited by 210
Cholinesterase Inhibitors and Beyond
Pepeu, G., & Giovannini, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509787602861 · Cited by 209
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
Rees, T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00230-0 · Cited by 207
Plasma Aβ in Alzheimer's disease—up or down?
Zetterberg, H., & Blennow, K. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70503-8 · Cited by 200
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 198
The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J., Masters, C., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & M??ller-Hill, B. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00032 · Cited by 195
Atack, J. R., Perry, E. K., Bonham, J. R., Candy, J. M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02858.x · Cited by 194
Small, D. H., Michaelson, S., & Sberna, G. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00099-2 · Cited by 188
Rieger, F., & Vigny, M. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb01553.x · Cited by 186
The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease
Rees, T. M., & Brimijoin, S. (2003) · Drugs of today · doi:10.1358/dot.2003.39.1.740206 · Cited by 171 · cited 1×
“…al., 1986; Mesulam and Geula, 1990; Massoulié et al., 1993; Layer, 1995; Small et al., 1996; Kása et al., 1997; Grisaru et al., 1999; Talesa, 2001; Rees and Brimijoin, 2003; Ballard et al., 2005; Silman and Sussman, 2005; Frontiers in Molecular Neuroscience www.frontiersin.org September 2011 |…”
BackgroundNGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons
Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806133105 · Cited by 169
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex
Mori, F., Lai, C.-C., Fusi, F., & Giacobini, E. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00012 · Cited by 157
Fishman, E. B., Siek, G. C., MacCallum, R. D., Bird, E. D., Volicer, L., & Marquis, J. K. (1986) · Annals of Neurology · doi:10.1002/ana.410190305 · Cited by 146
Zimmermann, M., Gardoni, F., Marcello, E. E., Colciaghi, F., Borroni, B., Padovani, A., Cattabeni, F., & Luca, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02680.x · Cited by 143
Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease
Geula, C., & Mesulam, M. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90419-8 · Cited by 140
Sternfeld, M., Shoham, S., Klein, O., Flores‐Flores, C., Evron, T., Idelson, G. H., Kitsberg, D., Patrick, J. W., & Soreq, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140004597 · Cited by 138
Deletion of M 1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo
Davis, A. A., Fritz, J. J., Wess, J., Lah, J. J., & Levey, A. I. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6393-09.2010 · Cited by 137
Lahiri, D. K., Chen, D., Maloney, B., Holloway, H. W., Yu, Q.-S., Utsuki, T., Giordano, T., Sambamurti, K., & Greig, N. H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112102 · Cited by 137
Sberna, G., Sáez‐Valero, J., Beyreuther, K. T., Masters, C. L., & Small, D. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031177.x · Cited by 132
Altered Levels of Acetylcholinesterase in Alzheimer Plasma
García‐Ayllón, M., Llena, I. R., Serra‐Basante, C., Alom, J., Boopathy, R., & Sáez‐Valero, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008701 · Cited by 129
Self-citationCholinesterases within neurofibrillary tangles related to age and Alzheimer's disease
Mesulam, M. M., & Morán, M. A. (1987) · Annals of Neurology · doi:10.1002/ana.410220206 · Cited by 128
Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines
Lahiri, D. K., Lewis, S., & Farlow, M. R. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370612 · Cited by 118
Davidsson, P., Blennow, K., Andreasen, N., Eriksson, B., Minthon, L., & Hesse, C. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01586-5 · Cited by 112
Combinatorial Complexity of 5′ Alternative Acetylcholinesterase Transcripts and Protein Products
Meshorer, E., Toiber, D., Zurel, D., Sahly, I., Dori, A., Cagnano, E., Schreiber, L., Grisaru, D., Tronche, F., & Soreq, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402752200 · Cited by 111
Dong, H., Yuede, C. M., Coughlan, C. A., Murphy, K. M., & Csernansky, J. G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.097 · Cited by 109
Sáez‐Valero, J., Sberna, G., McLean, C., & Small, D. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721600.x · Cited by 108
Rotundo, R. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77646-7 · Cited by 107
N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
Toiber, D., Berson, A., Greenberg, D., Melamed‐Book, N., Diamant, S., & Soreq, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003108 · Cited by 107
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology
Berson, A., Knobloch, M., Hanan, M., Diamant, S., Sharoni, M. A., Schuppli, D., Geyer, B. C., Ravid, R., Mor, T. S., Nitsch, R. M., et al. (2007) · Brain · doi:10.1093/brain/awm276 · Cited by 106
ULRICH, J., Meier‐Ruge, W., Probst, A., Meier, E., & Ipsen, S. (1990) · Acta Neuropathologica · doi:10.1007/bf00307630 · Cited by 105
Sihlbom, C., Davidsson, P., Sjögren, M. J. C., Wahlund, L., & Nilsson, C. L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9588-x · Cited by 104
Sberna, G., Sáez‐Valero, J., Li, Q.-X., Czech, C., Beyreuther, K., Masters, C. L., McLean, C., & Small, D. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020723.x · Cited by 103
Perry, R. H., Blessed, G., Perry, E. K., & Tomlinson, B. E. (1980) · Age and Ageing · doi:10.1093/ageing/9.1.9 · Cited by 102
Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ disease
Giacobini, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_17 · Cited by 100
Cholinesterases in neural development: new findings and toxicologic implications.
Brimijoin, S., & Koenigsberger, C. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s159 · Cited by 99
Glycosylation changes in Alzheimer’s disease as revealed by a proteomic approach
Kanninen, K. M., Goldsteins, G., Auriola, S. O. K., Alafuzoff, I. I., & Koıstınaho, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.013 · Cited by 97
Hu, W. T., Gray, N. W., & Brimijoin, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01855.x · Cited by 85
MULLER, F. M., Dumez, Y., & Massoulié, J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91555-0 · Cited by 76
Darreh‐Shori, T., Meurling, L., Pettersson, T., Hugosson, K. J. E., Hellström‐Lindahl, E., Andreasen, N. C., Minthon, L., & Nordberg, A. K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0526-2 · Cited by 76
Dori, A., Cohen, J., Silverman, W. F., Pollack, Y., & Soreq, H. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh145 · Cited by 75
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
Zimmermann, M., Borroni, B., Cattabeni, F., Padovani, A., & Luca, M. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.002 · Cited by 70
Molecular forms of acetylcholinesterases in Alzheimer's disease.
Sg, Y., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M., & Younkin, L. H. (1986) · PubMed · Cited by 63
Fu, H., Li, W., Luo, J., Lee, N. T. K., Li, M., Tsim, K. W. K., Pang, Y., Youdim, M. B. H., & Han, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.068 · Cited by 62
Rakonczay, Z. (2003) · Acta Biologica Hungarica · doi:10.1556/abiol.54.2003.2.7 · Cited by 59
Peng, Y., Jiang, L., Lee, D. Y. W., Schachter, S. C., Ma, Z., & Lemere, C. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20987 · Cited by 58
Inestrosa, N., Reiness, C. G., Reichardt, L. F., & Hall, Z. W. (1981) · Journal of Neuroscience · doi:10.1523/jneurosci.01-11-01260.1981 · Cited by 57
HAMMOND, P. I., & Brimijoin, S. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10580.x · Cited by 57
Altered Glycosylation Pattern of Proteins in Alzheimer Disease
Guevara, J., Espinosa, B., Zenteno, E., Vázquez, L., Luna, J., Perry, G. L., & Mena, R. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199810000-00003 · Cited by 55
Targeting Acetylcholinesterase to Membrane Rafts
Xie, H. Q., Liang, D., Leung, K. W., Chen, V. P., Zhu, K. Y., Chan, W. K. B., Choi, R. C. Y., Massoulié, J., & Tsim, K. W. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038711 · Cited by 54
Wheat germ agglutinin‐binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid
Fodero, L. R., Sáez‐Valero, J., Jiménez, M. S. B., Marcos, A., McLean, C., & Small, D. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00640.x · Cited by 53
García‐Ayllón, M., Silveyra, M. X., Candela, A., Compañ, A., Clària, J., Jover, R., Pérez‐Mateo, M., Felipo, V., Martínez, S., Galcerán, J., et al. (2006) · Hepatology · doi:10.1002/hep.21071 · Cited by 50
Self-citationPolymorphism of Acetylcholinesterase in Discrete Regions of the Developing Human Fetal Brain
Zakut, H. V., Matzkel, A., Schejter, E., Avni, A., & Soreq, H. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb03999.x · Cited by 50
Existence of an inactive pool of acetylcholinesterase in chicken brain.
Chatel, J., Grassi, J. J., Frobert, Y., Massoulié, J., & Vallette, F. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2476 · Cited by 49
Fodero, L. R., Sáez‐Valero, J., McLean, C., Martins, R. N., Beyreuther, K. T., Masters, C. L., Robertson, T. A., & Small, D. H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00902.x · Cited by 48
Preferential inhibition of acetylcholinesterase molecular forms in rat brain
Ogane, N., Giacobini, E., & Messamore, E. (1992) · Neurochemical Research · doi:10.1007/bf00969897 · Cited by 42
Sáez‐Valero, J. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.664 · Cited by 42
Lahiri, D. K., Farlow, M. R., Nürnberger, J. I., & Greig, N. H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48495.x · Cited by 41
Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
Sáez‐Valero, J., Sberna, G., McLean, C., Masters, C. L., & Small, D. H. (1997) · The Lancet · doi:10.1016/s0140-6736(97)24039-0 · Cited by 41
Neocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain
Perry, E. K., Smith, C. J., Atack, J. R., Candy, J. M., Johnson, M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00749.x · Cited by 41
Nonclassical Roles of Cholinesterases in the Embryonic Brain and Possible Links to Alzheimer Disease
Layer, P. G. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199501002-00006 · Cited by 40
Presenilin 1 Interacts with Acetylcholinesterase and Alters Its Enzymatic Activity and Glycosylation
Silveyra, M. X., Evin, G. M., Montenegro, M. F., Vidal, C. J., Martínez, S., Culvenor, J. G., & Sáez‐Valero, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02065-07 · Cited by 37
Non‐hydrolytic functions of acetylcholinesterase: The significance of C‐terminal peptides
Greenfield, S. A., Zimmermann, M., & Bond, C. E. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06235.x · Cited by 36
Sáez‐Valero, J., CEBALLOS, M. L. D., Small, D. H., & Felipe, C. D. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00282-3 · Cited by 35
Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice
Silveyra, M. X., García‐Ayllón, M., de Barreda, E. G., Small, D. H., Martínez, S., Ávila, J., & Sáez‐Valero, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.006 · Cited by 35
Self-citationParnetti, L., Chiasserini, D., Andréasson, U., Ohlson, M., Huls, C. E., Zetterberg, H., Minthon, L., Wallin, A., Andreasen, N. C., Talesa, V. N., et al. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01435.x · Cited by 35
Altered glycosylation of acetylcholinesterase in Creutzfeldt–Jakob disease
Silveyra, M. X., Cuadrado‐Corrales, N., Marcos, A., Jiménez, M. S. B., Rábano, A., Calero, M., & Sáez‐Valero, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03514.x · Cited by 33
Acetylcholinesterase-rich pyramidal neurons in alzheimer's disease
Heckers, S., Geula, C., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90072-6 · Cited by 32
Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels
Silveyra, M. X., García‐Ayllón, M., Serra‐Basante, C., Mazzoni, V., García‐Gutiérrez, M. S., Manzanares, J., Culvenor, J. G., & Sáez‐Valero, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.006 · Cited by 32
Self-citationAtack, J. R., Perry, E. K., Bonham, J. R., Candy, J. M., & Perry, R. H. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05724.x · Cited by 31
Basun, H., Nilsberth, C., Eckman, C. B., Lannfelt, L., & Younkin, S. G. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000063605 · Cited by 31
Li, Q., Wu, D., Zhang, L., & Zhang, Y. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.06.008 · Cited by 30
García‐Ayllón, M., Silveyra, M. X., Andreasen, N., Brimijoin, S., Blennow, K., & Sáez‐Valero, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04461.x · Cited by 29
Self-citationThe Cholinesterases: From Genes to Proteins
Taylor, P. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.34.1.281 · Cited by 27
Molecular Genetics of Alzheimer's Disease
Verdile, G., & Martin, R. (2008) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-85383-1_8 · Cited by 26
Acetylcholinesterase Variants in Alzheimer’s Disease: From Neuroprotection to Programmed Cell Death
Greenberg, D., Toiber, D., Berson, A., & Soreq, H. (2010) · Neurodegenerative Diseases · doi:10.1159/000285507 · Cited by 25
White, A. R., Maher, F., Brazier, M. W., Jobling, M. F., Thyer, J., Stewart, L. R., Thompson, A., Gibson, R., Masters, C. L., Multhaup, G., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04173-2 · Cited by 23
An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
Sáez‐Valero, J., Ss, S. S. S., & Small, D. H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00307.x · Cited by 22
On Functions of Cholinesterases During Embryonic Development
Sperling, L. E., Steinert, G., Klaczinski, J., Becker-Röck, M., Bytyqi, A. H., & Layer, P. G. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:201 · Cited by 21
Stieger, S., Brodbeck, U., & Witzemann, V. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02887.x · Cited by 16
Developmental regulation of mouse brain monomeric acetylcholinesterase
Moreno, R. D., Campos, E. O., Dajas, F., & Inestrosa, N. C. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00008-2 · Cited by 15
Cited by
Emerging Targets in Photopharmacology
Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymanski, W., & Feringa, B. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601931 · Cited by 675
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Walczak-Nowicka, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 335
The role of protein glycosylation in Alzheimer disease
Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014) · The FEBS Journal · doi:10.1111/febs.12590 · Cited by 317
Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 257
Metadata
- Authors
- García-Ayllón, M.-S.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 4
- Pages
- 22-22
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2157016321
- Cited by
- 299
- References
- 110
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.